Research Capital Initiates Coverage of LSL Pharma Group

• Research Capital initiated equity research coverage of LSL Pharma Group (TSXV: LSL) on Oct. 21, 2026.
• Andre Uddin authored the report, the company's first coverage by an independent equity research group.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LSL Pharma Group Inc. published the original content used to generate this news brief via CNW (Ref. ID: 202610210700CANADANWCANADAPR_C7876) on October 21, 2026, and is solely responsible for the information contained therein.